Synthetic Biologics, Inc. (SYN)

Operating Income Growth

67.92%

TTM · Period ending:

SYN logo

SYN Operating Income Growth

Year-over-year change vs the same period a year earlier

Latest reported67.92%
SYN TTM Operating Income YoY % (-70.10% → 67.92%)
High-resolution chart · PNG

SYN operating income growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Synthetic Biologics, Inc. Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
67.9178%
22.9781%
18.9001%
-56.7963%
-4.6627%
-12.1305%
-27.6016%
-36.0285%
-46.2018%
-74.9215%
-77.8992%
-65.5187%
-40.4528%
0.8631%
30.5658%
36.0431%
35.1296%
28.4659%
2.8334%
6.4075%
10.8645%
21.8252%
31.594%
30.0433%
33.0603%
34.4767%
36.3877%
37.2895%
33.127%
24.1611%
20.8478%
15.0713%
4.2167%
-10.2295%
-43.3604%
-74.3225%
-99.8829%
-107.5818%
-85.6957%
-78.4331%
-66.1561%
11.4174%
12.4573%
21.1874%
28.6722%
-147.645%
-157.3432%
-178.2662%
-191.8185%
-100.4126%
-87.6543%
-230.6384%
-272.7795%
-105.3461%
-106.1254%
48.1011%
57.0037%
44.3102%
57.5418%
29.8737%
49.4686%
63.4407%
57.7548%
48.9445%
27.8065%
12.8367%
-16.4409%
-46.9791%
-118.8467%
-1,970.0654%
-1,541.3639%
-312.5279%
-96.2047%
79.8201%
60.4073%
72.2979%
76.259%
49.9724%
16.3539%
-20.5658%
-63.8246%
-74.6638%
-53.7061%
-45.2971%
-22.0015%
-11.767%
-19.4185%
-17.1606%
-28.7884%
-42.7444%
-5.4435%
9.0909%
25.8065%
54.5455%
46.2366%
45%
37.3737%
-7.3171%
-29.1667%
-47.0588%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.